FDA approves Eli Lilly’s Alzheimer’s drug that slows memory decline
The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities…
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN — On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed to slow the…